| Ewell Nichols Jr, CRNA | |
|
50 Union Street, Ellsworth, ME 04605-1586 | |
| (207) 664-5304 | |
| (207) 664-5305 |
| Full Name | Ewell Nichols Jr |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 24 Years |
| Location | 50 Union Street, Ellsworth, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275603979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R042011 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barnes-jewish St Peters Hospital | Saint peters, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Anesthesia Providers Sc | 9830480581 | 139 |
News Archive
Guests Maria Shriver (First Lady-California) and Ann O'Leary (Berkeley Center for Health, Economic and Family Security) appeared yesterday to introduce The Shriver Report: A Woman's Nation takes on Alzheimer's on the ABC Sunday morning show This Week with Christiane Amanpour
Older patients with advanced hematologic malignancies, such as leukemia and lymphoma, who received a conditioning regimen that included minimal-intensity radiation therapy prior to allogeneic hematopoietic cell transplantation had survival and progression-free survival outcomes suggesting that this treatment approach may be a viable option for older patients with these malignancies, according to a study in the November 2 issue of JAMA.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
› Verified 6 days ago
| Entity Name | Metro-west Anesthesia Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245427335 PECOS PAC ID: 2163329921 Enrollment ID: O20031218000563 |
News Archive
Guests Maria Shriver (First Lady-California) and Ann O'Leary (Berkeley Center for Health, Economic and Family Security) appeared yesterday to introduce The Shriver Report: A Woman's Nation takes on Alzheimer's on the ABC Sunday morning show This Week with Christiane Amanpour
Older patients with advanced hematologic malignancies, such as leukemia and lymphoma, who received a conditioning regimen that included minimal-intensity radiation therapy prior to allogeneic hematopoietic cell transplantation had survival and progression-free survival outcomes suggesting that this treatment approach may be a viable option for older patients with these malignancies, according to a study in the November 2 issue of JAMA.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
› Verified 6 days ago
| Entity Name | Midwest Anesthesia Providers Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295189082 PECOS PAC ID: 9830480581 Enrollment ID: O20160712001846 |
News Archive
Guests Maria Shriver (First Lady-California) and Ann O'Leary (Berkeley Center for Health, Economic and Family Security) appeared yesterday to introduce The Shriver Report: A Woman's Nation takes on Alzheimer's on the ABC Sunday morning show This Week with Christiane Amanpour
Older patients with advanced hematologic malignancies, such as leukemia and lymphoma, who received a conditioning regimen that included minimal-intensity radiation therapy prior to allogeneic hematopoietic cell transplantation had survival and progression-free survival outcomes suggesting that this treatment approach may be a viable option for older patients with these malignancies, according to a study in the November 2 issue of JAMA.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ewell Nichols Jr, CRNA 50 Union Street, Ellsworth, ME 04605-1586 Ph: (207) 664-5304 | Ewell Nichols Jr, CRNA 50 Union Street, Ellsworth, ME 04605-1586 Ph: (207) 664-5304 |
News Archive
Guests Maria Shriver (First Lady-California) and Ann O'Leary (Berkeley Center for Health, Economic and Family Security) appeared yesterday to introduce The Shriver Report: A Woman's Nation takes on Alzheimer's on the ABC Sunday morning show This Week with Christiane Amanpour
Older patients with advanced hematologic malignancies, such as leukemia and lymphoma, who received a conditioning regimen that included minimal-intensity radiation therapy prior to allogeneic hematopoietic cell transplantation had survival and progression-free survival outcomes suggesting that this treatment approach may be a viable option for older patients with these malignancies, according to a study in the November 2 issue of JAMA.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
Emisphere Technologies, Inc. announced today that Novartis Pharma AG provided Emisphere with information regarding the First Interpretable Results of the two-year Phase III Study 2301 in osteoarthritis conducted by its license partner Nordic Bioscience with oral calcitonin (SMC021).
A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
› Verified 6 days ago
Elizabeth Mccann, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 50 Union Street, Ellsworth, ME 04605 Phone: 207-664-5304 Fax: 207-664-5305 | |
Enid M. Cox, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5304 Fax: 207-664-5305 | |
Mr. James Howard Mackey Iii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5311 Fax: 207-664-5305 | |
Mary Elizabeth Talley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5304 Fax: 207-664-5305 |